These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17723179)

  • 1. Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation.
    Meng LH; Ding J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1460-5. PubMed ID: 17723179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvicine functions as novel topoisomerase II poison by binding to ATP pocket.
    Hu CX; Zuo ZL; Xiong B; Ma JG; Geng MY; Lin LP; Jiang HL; Ding J
    Mol Pharmacol; 2006 Nov; 70(5):1593-601. PubMed ID: 16914642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.
    Lu HR; Meng LH; Huang M; Zhu H; Miao ZH; Ding J
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):286-94. PubMed ID: 15592835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase.
    Lu HR; Zhu H; Huang M; Chen Y; Cai YJ; Miao ZH; Zhang JS; Ding J
    Mol Pharmacol; 2005 Oct; 68(4):983-94. PubMed ID: 16024664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
    Zhou J; Chen Y; Lang JY; Lu JJ; Ding J
    Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition.
    Cai YJ; Lu JJ; Zhu H; Xie H; Huang M; Lin LP; Zhang XW; Ding J
    Free Radic Biol Med; 2008 Sep; 45(5):627-35. PubMed ID: 18582559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
    Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae.
    Meng LH; He XX; Zhang JS; Ding J
    Acta Pharmacol Sin; 2001 Aug; 22(8):741-6. PubMed ID: 11749849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.
    Dey D; Hasan MM; Biswas P; Papadakos SP; Rayan RA; Tasnim S; Bilal M; Islam MJ; Arshe FA; Arshad EM; Farzana M; Rahaman TI; Baral SK; Paul P; Bibi S; Rahman MA; Kim B
    Front Oncol; 2022; 12():899009. PubMed ID: 35719997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
    Meng LH; Zhang JS; Ding J
    Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells.
    Miao ZH; Tang T; Zhang YX; Zhang JS; Ding J
    Int J Cancer; 2003 Aug; 106(1):108-15. PubMed ID: 12794765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity of salvicine, a novel diterpenoid quinone.
    Qing C; Zhang JS; Ding J
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):297-302. PubMed ID: 10452112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells.
    Meng L; Ding J
    FEBS Lett; 2001 Jul; 501(1):59-64. PubMed ID: 11457456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psammaplin A, a natural phenolic compound, has inhibitory effect on human topoisomerase II and is cytotoxic to cancer cells.
    Kim D; Lee IS; Jung JH; Lee CO; Choi SU
    Anticancer Res; 1999; 19(5B):4085-90. PubMed ID: 10628358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer.
    Chien CM; Yang JC; Wu PH; Wu CY; Chen GY; Wu YC; Chou CK; Tseng CH; Chen YL; Wang LF; Chiu CC
    Phytomedicine; 2019 Feb; 54():109-119. PubMed ID: 30668360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells.
    Snyder RD; Gillies PJ
    Environ Mol Mutagen; 2002; 40(4):266-76. PubMed ID: 12489117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
    Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
    Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
    Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
    Wang SJ; Peyrollier K; Bourguignon LY
    Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells.
    López-Lázaro M; Willmore E; Jobson A; Gilroy KL; Curtis H; Padget K; Austin CA
    J Nat Prod; 2007 Dec; 70(12):1884-8. PubMed ID: 18076140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.